Compounds > fosamprenavir
Page last updated: 2024-09-03

fosamprenavir and scopolamine hydrobromide

fosamprenavir has been researched along with scopolamine hydrobromide in 1 studies

Compound Research Comparison

Studies
(fosamprenavir)		Trials
(fosamprenavir)		Recent Studies (post-2010)
(fosamprenavir)		Studies
(scopolamine hydrobromide)		Trials
(scopolamine hydrobromide)		Recent Studies (post-2010) (scopolamine hydrobromide)
17455377,5485631,401

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)scopolamine hydrobromide (IC50)
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.003
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.006
Cytochrome P450 3A4Homo sapiens (human)0.0006
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.006
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0026

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for fosamprenavir and scopolamine hydrobromide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016